Furthermore, HDAC5 mRNA and protein have been detected in the blood of patients with CRC (32, 33) and breast cancer (34), but not in that of healthy subjects or patients with nonrecurrent cancer, suggesting that circulating HDAC5 may serve as a potential biomarker for cancer diagnosis and prognosis. Here, HDAC5 is linked to cancer.